首页 > 最新文献

Annals of Internal Medicine最新文献

英文 中文
Annals for Educators - November 2024. 教育工作者年鉴》--2024 年 11 月。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 DOI: 10.7326/ANNALS-24-03423-ED
Christine Laine
{"title":"Annals for Educators - November 2024.","authors":"Christine Laine","doi":"10.7326/ANNALS-24-03423-ED","DOIUrl":"10.7326/ANNALS-24-03423-ED","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":"177 11","pages":"e2403423ED"},"PeriodicalIF":19.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19. COVID-19 的长期自身免疫性风湿病结果
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 DOI: 10.7326/ANNALS-24-01954
Min Seo Kim, Hayeon Lee, Dong Keon Yon
{"title":"Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19.","authors":"Min Seo Kim, Hayeon Lee, Dong Keon Yon","doi":"10.7326/ANNALS-24-01954","DOIUrl":"10.7326/ANNALS-24-01954","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":"177 11","pages":"1599-1600"},"PeriodicalIF":19.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Integrating Suicide Care in Primary Care : Secondary Analysis of a Stepped-Wedge, Cluster Randomized Implementation Trial. 将自杀护理纳入初级保健的有效性 :阶梯式楔形分组随机实施试验的二次分析》。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 Epub Date: 2024-10-01 DOI: 10.7326/M24-0024
Julie Angerhofer Richards, Maricela Cruz, Christine Stewart, Amy K Lee, Taylor C Ryan, Brian K Ahmedani, Gregory E Simon

Background: Primary care encounters are common among patients at risk for suicide.

Objective: To evaluate the effectiveness of implementing population-based suicide care (SC) in primary care for suicide attempt prevention.

Design: Secondary analysis of a stepped-wedge, cluster randomized implementation trial. (ClinicalTrials.gov: NCT02675777).

Setting: 19 primary care practices within a large health care system in Washington State, randomly assigned launch dates.

Patients: Adult patients (aged ≥18 years) with primary care visits from January 2015 to July 2018.

Intervention: Practice facilitators, electronic medical record (EMR) clinical decision support, and performance monitoring supported implementation of depression screening, suicide risk assessment, and safety planning.

Measurements: Clinical practice and patient measures relied on EMR and insurance claims data to compare usual care (UC) and SC periods. Primary outcomes included documented safety planning after population-based screening and suicide risk assessment and suicide attempts or deaths (with self-harm intent) within 90 days of a visit. Mixed-effects logistic models regressed binary outcome indicators on UC versus SC, adjusted for randomization stratification and calendar time, accounting for repeated outcomes from the same site. Monthly outcome rates (percentage per 10 000 patients) were estimated by applying marginal standardization.

Results: During UC, 255 789 patients made 953 402 primary care visits and 228 255 patients made 615 511 visits during the SC period. The rate of safety planning was higher in the SC group than in the UC group (38.3 vs. 32.8 per 10 000 patients; rate difference, 5.5 [95% CI, 2.3 to 8.7]). Suicide attempts within 90 days were lower in the SC group than in the UC group (4.5 vs. 6.0 per 10 000 patients; rate difference, -1.5 [CI, -2.6 to -0.4]).

Limitation: Suicide care was implemented in combination with care for depression and substance use.

Conclusion: Implementation of population-based SC concurrent with a substance use program resulted in a 25% reduction in the suicide attempt rate in the 90 days after primary care visits.

Primary funding source: National Institute of Mental Health.

背景:在有自杀风险的患者中,基层医疗机构的接诊很常见:在有自杀风险的患者中,基层医疗机构是常见的:评估在初级保健中实施基于人群的自杀护理(SC)以预防自杀未遂的效果:设计:对阶梯式、分组随机实施试验进行二次分析。(临床试验:NCT02675777):设置:华盛顿州一个大型医疗保健系统内的 19 个初级保健诊所,随机分配启动日期:成人患者(年龄≥18岁),2015年1月至2018年7月期间接受初级保健就诊:实践促进者、电子病历(EMR)临床决策支持和绩效监控支持抑郁症筛查、自杀风险评估和安全规划的实施:临床实践和患者测量依赖于 EMR 和保险理赔数据,以比较常规护理(UC)和 SC 阶段。主要结果包括基于人群的筛查和自杀风险评估后记录的安全计划,以及就诊后 90 天内的自杀未遂或死亡(有自残意图)。混合效应逻辑模型对 UC 和 SC 的二元结果指标进行了回归,并对随机分层和日历时间进行了调整,同时考虑了同一地点的重复结果。每月结果率(每 10,000 名患者中的百分比)通过边际标准化进行估算:在 UC 期间,255 789 名患者接受了 953 402 次初级保健就诊,而在 SC 期间,228 255 名患者接受了 615 511 次就诊。就诊安全计划的比例在就诊安全计划组高于综合治疗组(每 10,000 名患者中 38.3 对 32.8;比例差异为 5.5 [95% CI,2.3 至 8.7])。在90天内自杀未遂的患者中,SC组少于UC组(每万名患者中4.5例 vs. 6.0例;比率差异为-1.5 [CI, -2.6 to -0.4]):局限性:自杀护理与抑郁症和药物使用护理同时实施:主要资金来源:美国国家精神卫生研究所(National Institute of Mental Health):主要资金来源:美国国家心理健康研究所。
{"title":"Effectiveness of Integrating Suicide Care in Primary Care : Secondary Analysis of a Stepped-Wedge, Cluster Randomized Implementation Trial.","authors":"Julie Angerhofer Richards, Maricela Cruz, Christine Stewart, Amy K Lee, Taylor C Ryan, Brian K Ahmedani, Gregory E Simon","doi":"10.7326/M24-0024","DOIUrl":"10.7326/M24-0024","url":null,"abstract":"<p><strong>Background: </strong>Primary care encounters are common among patients at risk for suicide.</p><p><strong>Objective: </strong>To evaluate the effectiveness of implementing population-based suicide care (SC) in primary care for suicide attempt prevention.</p><p><strong>Design: </strong>Secondary analysis of a stepped-wedge, cluster randomized implementation trial. (ClinicalTrials.gov: NCT02675777).</p><p><strong>Setting: </strong>19 primary care practices within a large health care system in Washington State, randomly assigned launch dates.</p><p><strong>Patients: </strong>Adult patients (aged ≥18 years) with primary care visits from January 2015 to July 2018.</p><p><strong>Intervention: </strong>Practice facilitators, electronic medical record (EMR) clinical decision support, and performance monitoring supported implementation of depression screening, suicide risk assessment, and safety planning.</p><p><strong>Measurements: </strong>Clinical practice and patient measures relied on EMR and insurance claims data to compare usual care (UC) and SC periods. Primary outcomes included documented safety planning after population-based screening and suicide risk assessment and suicide attempts or deaths (with self-harm intent) within 90 days of a visit. Mixed-effects logistic models regressed binary outcome indicators on UC versus SC, adjusted for randomization stratification and calendar time, accounting for repeated outcomes from the same site. Monthly outcome rates (percentage per 10 000 patients) were estimated by applying marginal standardization.</p><p><strong>Results: </strong>During UC, 255 789 patients made 953 402 primary care visits and 228 255 patients made 615 511 visits during the SC period. The rate of safety planning was higher in the SC group than in the UC group (38.3 vs. 32.8 per 10 000 patients; rate difference, 5.5 [95% CI, 2.3 to 8.7]). Suicide attempts within 90 days were lower in the SC group than in the UC group (4.5 vs. 6.0 per 10 000 patients; rate difference, -1.5 [CI, -2.6 to -0.4]).</p><p><strong>Limitation: </strong>Suicide care was implemented in combination with care for depression and substance use.</p><p><strong>Conclusion: </strong>Implementation of population-based SC concurrent with a substance use program resulted in a 25% reduction in the suicide attempt rate in the 90 days after primary care visits.</p><p><strong>Primary funding source: </strong>National Institute of Mental Health.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"1471-1481"},"PeriodicalIF":19.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142339552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Summary for Patients: Time-Restricted Eating in Adults With Metabolic Syndrome. 患者摘要:成人代谢综合征患者的限时进食:随机对照试验。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 Epub Date: 2024-10-01 DOI: 10.7326/P24-0006
{"title":"Summary for Patients: Time-Restricted Eating in Adults With Metabolic Syndrome.","authors":"","doi":"10.7326/P24-0006","DOIUrl":"10.7326/P24-0006","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"I30"},"PeriodicalIF":19.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142339565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shortfalls in Follow-up Albuminuria Quantification After an Abnormal Result on a Urine Protein Dipstick Test. 尿蛋白浸量棒检测结果异常后,随访白蛋白尿定量的不足之处。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 Epub Date: 2024-10-01 DOI: 10.7326/ANNALS-24-00549
Yunwen Xu, Jung-Im Shin, Amelia Wallace, Juan J Carrero, Lesley A Inker, Amrita Mukhopadhyay, Saul B Blecker, Leora I Horwitz, Morgan E Grams, Alexander R Chang
{"title":"Shortfalls in Follow-up Albuminuria Quantification After an Abnormal Result on a Urine Protein Dipstick Test.","authors":"Yunwen Xu, Jung-Im Shin, Amelia Wallace, Juan J Carrero, Lesley A Inker, Amrita Mukhopadhyay, Saul B Blecker, Leora I Horwitz, Morgan E Grams, Alexander R Chang","doi":"10.7326/ANNALS-24-00549","DOIUrl":"10.7326/ANNALS-24-00549","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"1593-1595"},"PeriodicalIF":19.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142339564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Misplaced Push to Restrict Access to Gabapentin. 错误地推动限制加巴喷丁的使用。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 Epub Date: 2024-10-01 DOI: 10.7326/ANNALS-24-00940
Geoff Hollett, Karen Dionesotes, Joshua M Cohen, Noel Deep, Jennie B Jarrett
{"title":"The Misplaced Push to Restrict Access to Gabapentin.","authors":"Geoff Hollett, Karen Dionesotes, Joshua M Cohen, Noel Deep, Jennie B Jarrett","doi":"10.7326/ANNALS-24-00940","DOIUrl":"10.7326/ANNALS-24-00940","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"1575-1576"},"PeriodicalIF":19.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142339566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Quality Indicators for Pain in Adults. 更正:成人疼痛质量指标。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 Epub Date: 2024-10-29 DOI: 10.7326/ANNALS-24-03067
{"title":"Correction: Quality Indicators for Pain in Adults.","authors":"","doi":"10.7326/ANNALS-24-03067","DOIUrl":"10.7326/ANNALS-24-03067","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"1600"},"PeriodicalIF":19.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142520768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In T2D, SGLT-2 inhibitor effects on CV and kidney outcomes were consistent regardless of GLP-1 receptor agonist use. 在 T2D 患者中,无论是否使用 GLP-1 受体激动剂,SGLT-2 抑制剂对心血管和肾脏结果的影响都是一致的。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 Epub Date: 2024-11-05 DOI: 10.7326/ANNALS-24-02849-JC
Michelle Maher, Sean Dinneen

Source citation: Apperloo EM, Neuen BL, Fletcher RA, et al. Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 2024;12:545-557. 38991584.

来源引用:Apperloo EM、Neuen BL、Fletcher RA 等:SGLT2 抑制剂联合或不联合胰高血糖素样肽 1 受体激动剂的疗效和安全性:随机对照试验 SMART-C 合作荟萃分析。Lancet Diabetes Endocrinol.2024;12:545-557.38991584.
{"title":"In T2D, SGLT-2 inhibitor effects on CV and kidney outcomes were consistent regardless of GLP-1 receptor agonist use.","authors":"Michelle Maher, Sean Dinneen","doi":"10.7326/ANNALS-24-02849-JC","DOIUrl":"10.7326/ANNALS-24-02849-JC","url":null,"abstract":"<p><strong>Source citation: </strong>Apperloo EM, Neuen BL, Fletcher RA, et al. <b>Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials.</b> Lancet Diabetes Endocrinol. 2024;12:545-557. 38991584.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"JC124"},"PeriodicalIF":19.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142574766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19. COVID-19 的长期自身免疫性风湿病结果
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 DOI: 10.7326/ANNALS-24-01953
Takuma Hayashi, Ikuo Konishi
{"title":"Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19.","authors":"Takuma Hayashi, Ikuo Konishi","doi":"10.7326/ANNALS-24-01953","DOIUrl":"10.7326/ANNALS-24-01953","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":"177 11","pages":"1598-1599"},"PeriodicalIF":19.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Web Exclusive. Annals Consult Guys - Cardiac Medication Management in the Perioperative Period. 网络独家。Annals Consult Guys - 围手术期的心脏病药物管理。
IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 DOI: 10.7326/ANNALS-24-03425-CG
Howard H Weitz, Geno J Merli, James W Heitz
{"title":"Web Exclusive. Annals Consult Guys - Cardiac Medication Management in the Perioperative Period.","authors":"Howard H Weitz, Geno J Merli, James W Heitz","doi":"10.7326/ANNALS-24-03425-CG","DOIUrl":"10.7326/ANNALS-24-03425-CG","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":"177 11","pages":"e2403425CG"},"PeriodicalIF":19.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1